US-FDA completes inspection of Aurobindo's Vizag plant

Mumbai, May 31 (UNI) Aurobindo Pharma Ltd today announced that the US FDA has successfully inspected and rated Unit XI, one of the API manufacturing facilities, as ''Acceptable'' -- complying to all GMP (General Medical Practitioner) requirements.

Informing the BSE, the Company said apart from US FDA approval, this facility also holds local FDA, WHO GMP Certificate (Drug Control Admn. A.P., India) and ISO 9001-2000 certification.

The facility is spread over 110 acres of land and consists of eleven production blocks. It is one of the prestigious and biggest manufacturing facility of the Company.

UNI SN PM AG1615